Rauwolfia Serpentina Tablets
If you find any inaccurate information, please let us know by providing your feedback here
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
Rauwolfia Serpentina Tablets contain an amount of reserpine-rescinnamine group alkaloids, calculated as reserpine, equivalent to not less than 0.15 percent and not more than 0.20 percent of the labeled amount of powdered Rauwolfia serpentina.
Packaging and storage—Preserve in tight, light-resistant containers.
USP Reference standards 〈11〉—
USP Rauwolfia Serpentina RS
USP Reserpine RS
Identication—The powdered Rauwolfia serpentina in the Tablets conforms to the requirements for Ground Rauwolfia Serpentina root under Botanic characteristics and meets the requirements of the test for Chemical identification under Rauwolfia Serpentina. Microbial enumeration tests 〈61〉 and Tests for specified microorganisms 〈62〉—Tablets meet the requirements of the test for absence of Salmonella species.
Disintegration 〈701〉: 1 hour, with disks using simulated gastric uid TS, without enzyme.
Uniformity of dosage units 〈905〉: meet the requirements.
Assay—Weigh and finely powder not less than 20 Tablets. Weigh accurately a portion of this powder, equivalent to 2.5 g of powdered Rauwolfia serpentina, and proceed as directed for Procedure in the Assay under Rauwolfia Serpentina.
